Abstract

Polyetherurethanes (PEUs) based on polytetramethylene oxide (PTMO) as the polyol, and derivatized with propyl sulfonate functionality, have previously been shown to possess antithrombotic properties. In this article, the bulk physical properties of sulfonated and nonsulfonated polyurethanes containing either polyethylene oxide (PEO) or PTMO as the soft segment are studied. The in vitro shape-change of platelets in contact with these surfaces, and their ex vivo blood-contacting response are also investigated. It was found that PEO-base was physically weaker than PTMO-base, which is attributed to a lower degree or phase separation in the former. In the dry state, sulfonation enhanced the physical properties for PTMO-containing polyurethane (PTMO-SO3-0.20), but weakened the PEO-containing polyurethane (PEO-SO3-0.15). In vitro platelet spreading studies showed the lowest degree of platelet spreading and also the lowest platelet density on PEO-base, while platelet spreading and density on the other three materials and polyethylene (PE) was greater. The thromboresistance of these materials was evaluated using a canine arteriovenous series shunt ex vivo. It was determined that PTMO-SO3-0.20 was the least thrombogenic, followed by both PEO-base and PEO-SO3-0.15, and that PTMO-base was the most thrombogenic.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.